20468 ⎘
Medicinal preparations containing organic active ingredients; Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
Sub-classes:REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS
#2SOLUBLE ESTRADIOL CAPSULE FOR VAGINAL INSERTION
#3TOPICAL COMPOSITIONS COMPRISING AN ESTETROL COMPONENT AND USE OF SAID COMPOSITIONS FOR WOUND HEALING
#42,4 DNP and Prodrugs Thereof for Treatment of Cancer
#5CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS
#6Dosing Regimens for Elagolix
#7ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
#8COMPOSITIONS FOR NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR
#9METAL CHELATING COMPOSITIONS AND METHODS FOR CONTROLLING THE GROWTH OR ACTIVITIES OF A LIVING CELL OR ORGANISM
#10LONG ACTING DRUG DELIVERY DEVICE AND ITS USE IN CONTRACEPTION
#11COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER
#12COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#13NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#14VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#15DOSING REGIMENS COMPRISING A KAT6 INHIBITOR FOR THE TREATMENT OF CANCER
#16COMBINATIONS COMPRISING METAP2 INHIBITORS FOR THE TREATMENT OF CANCER
#17METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#18VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#19VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#20Method and System for Tuning Hormone Receptors through the Dynamic Intravenous Delivery of a Hormone According to a Target Physiological Cadence
#21COMPOSITIONS AND METHODS INVOLVING ADGRG6
#22TRANSDERMAL PACKAGING MEMBRANES
#23METHODS USING COMBINED ORAL CONTRACEPTIVE COMPOSITIONS WITH REDUCED CARDIOVASCULAR EFFECTS
#24ELASTIC SHEET WITH FUNCTION OF RE-ACTIVATING ENDOMETRIAL BASAL LAYER IN UTERINE CAVITY AND FORMING METHOD THEREOF
#25VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#26ADAPTER FOR USE IN A PLANETARY MIXER
#27COMPOSITIONS AND METHODS FOR NUCLEIC ACID TRANSFER
#28DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
#29Natural Combination Hormone Replacement Formulations and Therapies
#30CONTRACEPTIVE COMPOSITIONS AND METHODS FOR IMPROVED EFFICACY AND MODULATION OF SIDE EFFECTS
#31ORAL PHARMACEUTICAL COMPOSITIONS OF PROGESTERONE AND ESTRADIOL
#32METHOD OF ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL WITH A DUAL CHAMBER SYRINGE
#33HORMONE REPLENISHMENT METHOD WITH A HYDROGEL POLYMER
#34COMPOSITION OF HYDROGEL LOADED WITH HORMONE
#35DUAL CHAMBER SYRINGE FOR ADMINISTERING A HORMONE ENCAPSULATED BY A HYDROGEL
#36TREATMENT OF DYSMENORRHEA
#37THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS
#38FULVESTRANT FORMULATIONS
#39INTRAVAGINAL RING
#40D2O STABILIZED PHARMACEUTICAL FORMULATIONS
#41THERAPEUTICALLY ACTIVE STEROIDAL DERIVATIVES
#42Compositions Comprising 5-Cholesten-3, 25-Diol, 3-Sulfate (25HC3S) or Pharmaceutically Acceptable Salt Thereof And at Least One Cyclic Oligosaccharide
#43COMBINATION METABOLIC-EPIGENETIC TREATMENT FOR EARLY LUNG CANCER
#44COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#45A DUAL SELECTIVE PI3K DELTA AND GAMMA INHIBITORS AND/OR A SALT-INDUCIBLE KINASE 3 INHIBITOR FOR TREATING SOLID TUMORS
#46Methods Of Treating Decreased Bone Mineral Density With Cluster Of Differentiation 109 (CD109) Inhibitors
#47DISSOLVABLE-CHEWABLE TABLET
#48FULVESTRANT FORMULATIONS
#49METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#50Polymorphic Compounds And Uses Thereof
#51HIGH DRUG-LOADING FULVESTRANT PHARMACEUTICAL COMPOSITION AND PREPARATION METHOD THEREOF
#52COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#53COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#54METHODS OF TREATING EOSINOPHILIC ESOPHAGITIS
#55DRUG DELIVERY SYSTEM
#56CONTRACEPTIVE METHODS WITH IMPROVED PEARL INDEX
#57ETRASIMOD FOR USE IN TREATING S1P1 RECEPTOR-ASSOCIATED DISORDERS IN COMBINATION WITH HORMONE TREATMENT
#58NOVEL ESTROGEN RECEPTOR MUTATIONS AND USES THEREOF
#59METHODS OF TREATING CANCER WITH PI3K INHIBITOR, GDC-0077
#60METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR FOR THE TREATMENT OF CANCER
#61COMBINATION TREATMENT OF TUMORS
#62TETRAHYDRO-PYRIDO[3,4-b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
#63WOUND HEALING MEDICAMENT
#64COMPOSITIONS FOR PROMOTING HAIR GROWTH
#65ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE
#66GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS
#67ADAPTER FOR USE IN A PLANETARY MIXER
#68COMPOUNDS AND FORMS OF TREATMENT FOR FEMALE SEXUAL DISORDERS
#69LEVONORGESTREL BUTANOATE FORMULATION AND METHODS RELATING THERETO
#70CDK4 INHIBITOR FOR THE TREATMENT OF CANCER
#71METHODS AND DOSING REGIMENS COMPRISING A CDK2 INHIBITOR AND A CDK4 INHIBITOR FOR TREATING CANCER
#72WOUND HEALING MEDICAMENT
#73CO-FORMULATION AND CO-DELIVERY OF IONIZABLE COLLOID FORMING DRUGS WITH NUCLEIC ACIDS
#74RAPIDLY DISSOLVING SALT TABLET COMPOSITIONS AND METHODS
#75USES OF HYALURONAN CONJUGATES
#76Vaginal Drug Delivery Device
#77CDK4 AND 6 INHIBITOR IN COMBINATION WITH FULVESTRANT FOR THE TREATMENT OF HORMONE RECEPTOR-POSITIVE, HUMAN EPIDERMAL GROWTH FACTOR RECEPTOR 2-NEGATIVE ADVANCED OR METASTATIC BREAST CANCER IN PATIENTS PREVIOUSLY TREATED WITH A CDK4 AND 6 INHIBITOR
#78COMPOSITIONS COMPRISING SMALL MOLECULE REGULATORS OF TUMOR IMMUNITY AND METHODS OF USING SAME
#79METHODS OF TREATING ESTROGEN SENSITIVE DISEASES WITH CANNABIS EXTRACT
#80COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH
#81Drug Delivery System for Medical Devices
#82METHOD OF PROVIDING BIRTH CONTROL
#83LIVER X RECEPTOR MODULATORS
#84CDK Inhibitors And Their Use As Pharmaceuticals
#85VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#86Methods, Systems and Devices for Post-Fabrication Drug Loading
#87NOVEL THERAPEUTIC METHOD FOR ENHANCING MITOCHONDRIAL FUNCTION, TREATING MITOCHONDRIAL DISEASES THEREBY, AND COMPOUNDS USED THEREIN
#88USE OF ESTRETOL AS A TREATMENT FOR ENDOMETRIOSIS
#89COMPOSITIONS AND METHODS RELATED TO PHARMACEUTICAL EXCIPIENTS
#90METHOD AND DEVICE FOR PROVIDING EFFECTIVE CONTRACEPTION
#91METHOD AND DEVICE FOR PROVIDING EFFECTIVE CONTRACEPTION
#92THERAPEUTICALLY ACTIVE STEROIDAL DERIVATIVES
#93METHODS OF ADMINISTERING ELAGOLIX
#94CANCER THERAPY USING A COMBINATION OF CDK7 INHIBITOR WITH AN ANTI-CANCER AGENT
#95METHODS FOR INHIBITING MUSCLE ATROPHY
#96METHODS OF PROVIDING BIRTH CONTROL
#97EVA SEGMENTED INTRAVAGINAL RINGS CONTAINING PROGESTERONE
#98ORODISPERSIBLE DOSAGE UNIT CONTAINING AN ESTETROL COMPONENT
#99Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#100METHOD OF TREATING CANCER USING SELECTIVE ESTROGEN RECEPTOR MODULATORS
#101DISSOCIATING POLYMER MATRIX COMPOSITIONS OF FULVESTRANT AND METHODS OF THEIR MAKING AND USE
#102STABLE HEAVY ISOTOPES IN AMIDE FUNCTIONAL GROUPS AND USES THEREOF
#103APPLICATOR AND SYSTEM FOR ADMINISTERING AND DISPENSING FLOWABLE PHARMACEUTICAL PREPARATIONS
#104COMPOSITION USED FOR THERAPEUTIC TREATMENT OF SKIN DISEASE
#105NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR
#106Dosing Regimens for Elagolix
#107Vaginal Hydrogel
#108Treatment of Heavy Menstrual Bleeding Associated with Uterine Fibroids
#109Contraceptive Compositions and Methods for Improved Efficacy and Modulation of Side Effects
#110APPLICATIONS FOR ESTRADIOL IN PREPARING ANTI-SMALL CELL LUNG CANCER AND/OR OVARIAN CANCER AND/OR OSTEOSARCOMA PRODUCTS
#111CONTROLLED FLOW DRUG DELIVERY IMPLANTABLE DEVICE
#112ADAPTER FOR USE IN A PLANETARY MIXER
#113Methods of treating estrogen sensitive diseases with cannabis extract
#114COMBINED PHARMACEUTICAL COMPOSITION CONTAINING CDK4/6 INHIBITOR AND USE THEREOF
#115METHODS OF TREATING HYPOGONADOTROPIC HYPOGONADISM AND COGNITION IMPAIRMENT FOLLOWING A TRAUMATIC BRAIN INJURY
#116NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#117SEGMENTED EVA INTRAVAGINAL RINGS
#118COMPOSITIONS FOR TREATMENT OF NEURODEGENERATIVE CONDITIONS
#119Adapter for use in a planetary mixer
#120Methods Comprising Continuous Administration of a GLP-1 Receptor Agonist and Co-administration of a Drug
#121ADAPTER FOR USE IN A PLANETARY MIXER
#122IMMUNOISOLATION DEVICE
#123FULVESTRANT FORMULATIONS
#124A Pharmaceutical Composition for Treating Cancer
#125COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#126IMMUNORHELIN COMPOUNDS FOR INTRACELLULAR INFECTIONS
#127COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#128THERAPEUTIC COMBINATION FOR THE TREATMENT OF BREAST CANCER
#129GONADOTROPIN-RELEASING HORMONE ANTAGONIST DOSING REGIMENS FOR TREATING UTERINE FIBROIDS AND REDUCING MENSTRUAL BLOOD LOSS
#130STABLE HEAVY ISOTOPES IN AMIDE FUNCTIONAL GROUPS AND USES THEREOF
#131Methods of treating eosinophilic esophagitis
#132ADJUVANT THERAPY FOR USE IN PROSTATE CANCER TREATMENT
#133COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#134METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#135USE OF COMBINED ORAL CONTRACEPTIVES CONTAINING NOMEGESTROL ACETATE AND ESTRADIOL
#136COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#137Method of treating cancer using selective estrogen receptor modulators
#138METHODS OF CONTRACEPTION USING NOMEGESTROL ACETATE AND ESTRADIOL
#139Non-surgical prevention of boar taint and aggressive behavior
#140NON-SURGICAL PREVENTION OF UNPLEASANT ODOR IN MEATS AND AGGRESSIVE OR SEXUAL BEHAVIOR IN MALE RUMINANTS
#141PREVENTION OF ESTRUS IN SOW AND RUMINANTS
#142COMPOSITIONS FOR NON-SURGICAL PREVENTION OF BOAR TAINT AND AGGRESSIVE BEHAVIOR
#143Substituted benzothiophene analogs as selective estrogen receptor degraders
#144CDK Inhibitors And Their Use As Pharmaceuticals
#145DRUG-ELUTING DEVICE WITH GENETIC AND CHEMICAL THERAPEUTICS FOR TREATING OR PREVENTING VASCULAR ACCESS DYSFUNCTIONS
#146DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
#147Methods, Systems and Devices for Post-Fabrication Drug Loading
#148MULTIPHASIC CONTRACEPTIVE REGIMEN FOR ORAL COMBINATION DRUG FORMULATION OF PROGESTIN AND ESTROGEN
#149COMBINATION THERAPY
#150COMBINATION THERAPIES FOR TREATMENT OF HER2 CANCER
#151TREATMENT OF ER-NEGATIVE BREAST CANCER WITH AN PDGF-CC INHIBITOR AND AN ANTI-ESTROGEN
#152NATURAL COMBINATION HORMONE REPLACEMENT FORMULATIONS AND THERAPIES
#153Orodispersible dosage unit containing an estetrol component
#154METHODS OF TREATING HEAVY MENSTRUAL BLEEDING
#155STEROID HORMONE PHARMACEUTICAL FORMULATIONS
#156Methods of Administering Elagolix
#157PYRIMIDINE COMPOUND-CONTAINING COMBINATION TO BE USED IN TUMOR TREATMENT
#158Contraceptive methods with improved pearl index
#159SYSTEM FOR PROVIDING BIRTH CONTROL
#16017Beta-ESTRADIOL/VITAMIN C MOLECULAR COMPLEX, PREPARATION METHOD, AND USE THEREOF
#161ANIMAL STERILIZATION BY ESTROGENIC COMPOUNDS
#162Natural Combination Hormone Replacement Formulations and Therapies
#163MEDICAMENT USED FOR TREATING CHOLANGIOCARCINOMA WITH KRAS MUTATIONS
#164VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#165Controlled flow drug delivery implantable device
#166NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#167E PROTEIN CHANNEL BLOCKERS AND ORF3 INHIBITORS AS ANTI-COVID-19 AGENTS
#168THERAPEUTIC AGENT FOR BREAST CANCER
#169BREAST CANCER THERAPEUTIC AGENT
#170MULTIPHASIC CONTRACEPTIVE AND/OR HORMONE REPLACEMENT THERAPY
#171COMPOUNDS FOR METHODS FOR PROMOTING FEMALE REPRODUCTIVE HEALTH THROUGH MEDIATION OF RENIN ANGIOTENSIN FUNCTION
#172Method for the Production of Commercial Nanoparticle and Microparticle Powders
#173THERAPEUTIC BENEFIT OF SUBOPTIMALLY ADMINISTERED CHEMICAL COMPOUNDS
#174Method of treating cancer using selective estrogen receptor modulators
#175Composite Pharmaceutical Composition for Treatment of Fibrosis Disease
#176PHARMACEUTICAL COMBINATION COMPRISING PYRIDINO[1,2-A]PYRIMIDINONE COMPOUND
#177REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS
#178COMBINATION THERAPIES AND BIOMARKERS FOR TREATING CANCER
#179DEUTERATED SECNIDAZOLE FOR USE IN THE TREATMENT OF BACTERIAL VAGINOSIS AND METHODS AND USES THEREOF
#180METHOD OF PROVIDING BIRTH CONTROL
#181COMBINATION THERAPIES FOR TREATMENT OF BREAST CANCER
#182Hyaluronan conjugates and uses thereof
#183COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#184Contraceptive regimen including reduced level of estrogen
#185VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#186CHEMOPREVENTION USING CONTROLLED- RELEASE FORMULATIONS OF ANTI-INTERLEUKIN 6 AGENTS, SYNTHETIC VITAMIN A ANALOGUES OR METABOLITES, AND ESTRADIOL METABOLITES
#187NECROPTOSIS MODULATORS, SCREENING METHODS AND PHARMACEUTICAL COMPOSITIONS
#188Methods of treating decreased bone mineral density with cluster of differentiation 109 (CD109) inhibitors
#189COMBINATIONS
#190Compounds and their uses for alleviating menopause-associated symptoms
#191Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide
#192Tetrahydro-pyrido[3,4-b]indole estrogen receptor modulators and uses thereof
#193Method for preventing pregnancy
#194COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#195COMPOUNDS AND THEIR USES FOR ALLEVIATING MENOPAUSE-ASSOCIATED SYMPTOMS
#196Compounds and forms of treatment for female sexual disorders
#197TREATING CANCERS WITH A CYCLIN-DEPENDENT KINASE INHIBITOR
#198Use of Deoxycholic Acid, Derivatives, or Salts Thereof in Managing Bacterial Infections and Compositions Related Thereto
#199FULVESTRANT FORMULATIONS
#200ADJUSTABLE RATE DRUG DELIVERY IMPLANTABLE DEVICE
#201PREVENTION OF BOAR TAINT AND AGGRESSION
#202Treatment of heavy menstrual bleeding associated with uterine fibroids
#203Compositions and Methods for Increasing Epithelial Barrier Function
#204COMPOSITIONS AND METHODS FOR THE TREATMENT OF ESTROGEN-DEPENDENT DISORDERS
#205Sustained release estrogen vaginal ring pessary for treatment of atrophy, cystitis and uterovaginal prolapse
#206METHODS FOR INHIBITING MUSCLE ATROPHY
#207Vaginal hydrogel
#208REGIMENS OF ESTROGEN RECEPTOR ANTAGONISTS
#209Deuterated secnidazole for use in the treatment of bacterial vaginosis and methods and uses thereof
#210Estrogen receptor mutations and uses thereof
#211GANAXOLONE FOR USE IN TREATING GENETIC EPILEPTIC DISORDERS
#212METHODS FOR INCREASING RED BLOOD CELL LEVELS AND TREATING INEFFECTIVE ERYTHROPOIESIS
#213Methods of Treatments Based Upon Anthracycline Responsiveness
#214COMPOSITIONS AND PROCESS FOR INTEGRATING CELLS INTO EPITHELIUM
#215CONTRACEPTIVE COMPOSITIONS WITH REDUCED ADVERSE EFFECTS
#216Therapeutics and methods for predicting and overcoming endocrine resistance in breast cancer
#217COMBINATION THERAPY FOR THE TREATMENT OF CANCER
#218Implants for localized drug delivery and methods of use thereof
#219COMPOSITIONS AND METHODS FOR TREATING NEUROBLASTOMA
#220USE OF FULVESTRANT FOR THE THERAPEUTIC CARE OF CENTRAL CORE DISEASE
#221GEOMETRICALLY COMPLEX INTRAVAGINAL RINGS, SYSTEMS AND METHODS OF MAKING THE SAME
#222Vaginal hydrogel
#223COMPOSITIONS FOR THE TREATMENT OF CHRONIC VULVAL AND PERINEAL PAIN AND SYMPTOMS AND CONDITIONS ASSOCIATED THEREWITH
#224APPLICATIONS FOR ESTRADIOL IN PREPARING ANTI-SMALL CELL LUNG CANCER AND/OR OVARIAN CANCER AND/OR OSTEOSARCOMA PRODUCTS
#225Compositions and Methods for increasing Reproduction Performance in Non Human Mammals Using Recombinant Luteinizing Hormone
#226FULVESTRANT FORMULATIONS
#227Pharmaceutical composition of MDM2 inhibitor and use thereof for preventing and/or treating disease
#228ESTROGEN RECEPTOR INHIBITORS AND USES THEROF
#229THERAPEUTICALLY ACTIVE STEROIDAL DERIVATIVES
#230COMBINATION OF A CDK INHIBITOR AND A PIM INHIBITOR
#231FORMULATIONS AND METHODS FOR PROVIDING PROGESTIN-ONLY CONTRACEPTION
#232Compositions and methods for the treatment of adenomyosis and rectovaginal endometriosis
#233Method of treating cancer using selective estrogen receptor modulators
#234METHOD OF TREATING OR PREVENTING NEURODEGENERATION
#235INDOLE MOLECULES AND USE THEREOF IN THE INHIBITION OF DNA POLYMERASES
#236Orodispersible dosage unit containing an estetrol component
#237KLOTHO BETA
#238CDK inhibitors and their use as pharmaceuticals
#239METHODS FOR TREATING OR PREVENTING CANCER IN A KRAS-VARIANT PATIENT AND FOR DIAGNOSING RISK OF DEVELOPING MULTIPLE PRIMARY BREAST TUMORS
#240METHODS AND COMPOSITIONS FOR TREATING RESISTANT AND RECURRENT FORMS OF CANCER
#241Methods of treating heavy menstrual bleeding
#242ESTROGEN RECEPTOR PROTEIN DEGRADERS
#243FULVESTRANT FORMULATIONS
#244Substituted benzothiophene analogs as selective estrogen receptor degraders
#245VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#246COMBINATION THERAPY FOR THE TREATMENT OF ESTROGEN-RECEPTOR POSITIVE BREAST CANCER
#247Ethinyl estradiol-β-cyclodextrin complex and process for preparing thereof
#248THERAPEUTIC AND PROPHYLACTIC METHOD FOR TUMOR TREATABLE WITH ENDOCRINE THERAPY BY COMBINED USE OF FIBROBLAST GROWTH FACTOR RECEPTOR INHIBITOR WITH ENDOCRINE THERAPY
#249Transmucosal and transdermal delivery systems
#250TREATING BREAST CANCER WITH HORMONE RECEPTOR MODULATORS
#251VAGINAL INSERTED ESTRADIOL PHARMACEUTICAL COMPOSITIONS AND METHODS
#252Stable heavy isotopes in amide functional groups and uses thereof
#253Methods of treating endometriosis
#254Designing Treatments for Chemotherapy-Induced and Age-Related Menopausal Symptoms Using Combinations of Natural Products and Prescription Medications
#255DO stabilized pharmaceutical formulations
#256IMPROVEMENTS FOR PERFORMING AND FACILITATING THE RECOVERY AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION
#257REGULATING MUSCLE PHYSIOLOGY AND ENERGY METABOLISM USING CRYM
#258COMBINATIONS OF POSITIVE ALLOSTERIC MODULATORS AND NICOTINIC ACETYLCHOLINE RECEPTOR AGONISTS FOR TREATING OCULAR CONDITIONS
#259Methods for treating muscular dystrophies
#260P62 ligand compound, and composition for preventing, ameliorating or treating proteinopathies comprising the same
#261Multiphasic contraceptive regimen for oral combination drug formulation of progestin and estrogen
#262FULVESTRANT FORMULATIONS AND METHODS OF THEIR USE
#263Remyelination Therapy
#264COMBINATIONS OF TGF-BETA INHIBITORS AND CDK INHIBITORS FOR CANCER TREATMENTS
#265Methods of treating eosinophilic esophagitis
#266Gel Compositions for Transdermal Delivery to Maximize Drug Concentrations in the Stratum Corneum and Serum and Methods of Use Thereof
#267NOVEL ANTI-CANCER COMBINATION AND A METHOD OF THERAPY USING THE COMBINATION
#268Long acting drug delivery device and its use in contraception
#269MICRONEEDLE ARRAY PATCH FOR DRUG DELIVERY AND PRODUCTION METHOD THEREOF
#270METHODS OF TREATING CANCER WITH PI3K ALPHA INHIBITORS AND METFORMIN
#271MODULATORS OF PROSTATE-SPECIFIC G-PROTEIN RECEPTOR (PSGR/OR51E2) AND METHODS OF USING SAME
#272FULVESTRANT COMPOSITIONS AND METHOD OF USE
#273Synthesis and processing of poly(pro-drug) materials for extended drug release and uses thereof
#274NEUROACTIVE 19-ALKOXY-17-SUBSTITUTED STEROIDS, PRODRUGS THEREOF, AND METHODS OF TREATMENT USING SAME
#275Dosing Regimens for Elagolix
#276AUTOTAC chimeric compound, and composition for preventing, ameliorating or treating diseases through targeted protein degradation comprising the same
#277USE OF ESTETROL AS EMERGENCY CONTRACEPTIVE
#278KLOTHO BETA
#279DO stabilized pharmaceutical formulations
#280Secnidazole for use in the treatment of bacterial vaginosis
#281NEOANTIGENS AND USES THEREOF
#282METHODS OF TREATING HEAVY MENSTRUAL BLEEDING
#283Methods of administering elagolix
#284Methods of treating eosinophilic esophagitis
#285FULVESTRANT FORMULATIONS
#286Secnidazole for use in the treatment of sexually transmitted infection
#287METHODS OF TREATING CANCER WITH PI3K INHIBITOR, GDC-0077
#288UREA DERIVATIVES FOR USE IN THE TREATMENT OF SUBJECTS WITH ELEVATED EXPRESSION AND/OR ACTIVITY OF SRPK1
#289Steroid hormone pharmaceutical formulations
#290Methods comprising continuous administration of exenatide and co-administration of a drug
#291TETRAHYDRO- PYRIDO[3,4- b]INDOLE ESTROGEN RECEPTOR MODULATORS AND USES THEREOF
#292Estrogen therapy for brain gray matter atrophy and associated disability
#293Composition comprising a therapeutic agent and a CXCR4 selective antagonist and methods for using the same
#294ADAPTER FOR USE IN A PLANETARY MIXER
#295COMPOSITIONS FOR THE TREATMENT OF SKIN CONDITIONS
#296COMBINATION THERAPY
#297Treatment of ER-negative breast cancer with an PDGF-CC inhibitor and anti-estrogen
#298Adapter for use in a planetary mixer
#299Biodegradable liquogel and pH sensitive nanocarriers
#300Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide